Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 1,635,245 | 1,610,527 | 1,541,573 | 1,557,666 | 1,542,448 |
| Cost of Goods | 803,625 | 728,466 | 656,838 | 587,355 | 597,808 |
| Gross Profit | 831,620 | 882,061 | 884,735 | 970,311 | 944,640 |
| Operating Expenses | 1,325,615 | 854,116 | 774,047 | 731,746 | 748,218 |
| Operating Income | -493,370 | 28,411 | 111,526 | 238,920 | 197,230 |
| Interest Expense | 86,255 | 70,632 | 51,377 | 49,594 | 50,395 |
| Other Income | 16,123 | 23,984 | 20,920 | 24,568 | 67,842 |
| Pre-tax Income | -563,502 | -18,237 | 81,069 | 213,894 | 214,677 |
| Income Tax | -47,028 | -11,293 | 13,328 | 33,344 | 45,602 |
| Net Income Continuous | -516,474 | -6,944 | 67,741 | 180,550 | 169,075 |
| Net Income | $-516,474 | $-6,944 | $67,741 | $180,550 | $169,075 |
| EPS Basic Total Ops | -6.74 | -0.09 | 0.85 | 2.18 | 2.00 |
| EPS Basic Continuous Ops | -6.74 | -0.09 | 0.85 | 2.18 | 2.00 |
| EPS Diluted Total Ops | -6.74 | -0.09 | 0.84 | 2.16 | 1.98 |
| EPS Diluted Continuous Ops | -6.74 | -0.09 | 0.84 | 2.16 | 1.98 |
| EPS Diluted Before Non-Recurring Items | 2.23 | 2.56 | 3.10 | 3.36 | 3.18 |
| EBITDA(a) | $-335,933 | $174,897 | $241,202 | $364,064 | $324,096 |